GAB1 attenuates lipopolysaccharide‑mediated endothelial dysfunction via regulation of SOCS3

Ren,Guangdong; Liu,Ran; Mai,Huiqiang; Yin,Gang; Ding,Fulai; Wang,Chunmei; Chen,Shuxin; Lan,Xianqi

doi:10.3892/etm.2024.12689

GAB1 attenuates lipopolysaccharide‑mediated endothelial dysfunction via regulation of SOCS3

Authors:
- Guangdong Ren
- Ran Liu
- Huiqiang Mai
- Gang Yin
- Fulai Ding
- Chunmei Wang
- Shuxin Chen
- Xianqi Lan
View Affiliations

Affiliations: Emergency Department, Zhongshan City People's Hospital, Zhongshan, Guangdong 528403, P.R. China
Published online on: August 14, 2024 https://doi.org/10.3892/etm.2024.12689
Article Number: 400
Copyright: © Ren et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Endothelial dysfunction is a crucial pathogenetic mechanism for sepsis. GRB2‑associated binder 1 (GAB1) alleviates sepsis‑induced multi‑organ damage; however, to the best of our knowledge, its function in endothelial dysfunction in sepsis remains unclear. HUVECs were induced by lipopolysaccharide (LPS) to simulate endothelial cell injury under sepsis. Cell transfection was conducted to achieve GAB1 overexpression or suppressor of cytokine signaling 3 (SOCS3) knockdown. The expression levels of GAB1 and SOCS3 were detected by reverse transcription‑quantitative PCR and western blotting. Cell viability, apoptosis and migration were assessed using Cell Counting Kit‑8, TUNEL and wound healing assays, respectively. The production of cytokines and nitric oxide (NO) was detected using commercial kits. The interaction between GAB1 and SOCS3 was confirmed using a co‑immunoprecipitation assay. GAB1 was downregulated in LPS‑induced HUVECs. However, GAB1 overexpression significantly mitigated LPS‑induced cell viability decrease and apoptosis in HUVECs, accompanied by upregulation of Bcl2 expression, and downregulation of Bax and cleaved caspase‑3 expression. GAB1 also inhibited the production of pro‑inflammatory cytokines and increased NO level, increased the levels of endothelial NO synthase (eNOS) and phosphorylated (p)‑eNOS, and promoted migration in LPS‑induced HUVECs. However, SOCS3 knockdown partially weakened the effects of GAB1 overexpression on cell viability, apoptosis, inflammation, p‑eNOS, eNOS expression and NO levels in LPS‑induced HUVECs. In addition, GAB1 and SOCS3 regulated Janus kinase 2 (JAK2)/STAT3 signaling in LPS‑induced HUVECs. In conclusion, GAB1 exerted a protective effect against LPS‑induced endothelial cell apoptosis, inflammation and dysfunction by modulating the SOCS3/JAK2/STAT3 signaling pathway.

View Figures

View References

1	Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche JD, Coopersmith CM, et al: The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA. 315:801–810. 2016.PubMed/NCBI View Article : Google Scholar
2	Evans L, Rhodes A, Alhazzani W, Antonelli M, Coopersmith CM, French C, Machado FR, Mcintyre L, Ostermann M, Prescott HC, et al: Surviving sepsis campaign: International guidelines for management of sepsis and septic shock 2021. Crit Care Med. 49:e1063–e1143. 2021.PubMed/NCBI View Article : Google Scholar
3	Seymour CW, Kennedy JN, Wang S, Chang CCH, Elliott CF, Xu Z, Berry S, Clermont G, Cooper G, Gomez H, et al: Derivation, validation, and potential treatment implications of novel clinical phenotypes for sepsis. JAMA. 321:2003–2017. 2019.PubMed/NCBI View Article : Google Scholar
4	Xie J, Wang H, Kang Y, Zhou L, Liu Z, Qin B, Ma X, Cao X, Chen D, Lu W, et al: The epidemiology of sepsis in Chinese ICUs: A national cross-sectional survey. Crit Care Med. 48:e209–e218. 2020.PubMed/NCBI View Article : Google Scholar
5	van der Poll T, van de Veerdonk FL, Scicluna BP and Netea MG: The immunopathology of sepsis and potential therapeutic targets. Nat Rev Immunol. 17:407–420. 2017.PubMed/NCBI View Article : Google Scholar
6	Lelubre C and Vincent JL: Mechanisms and treatment of organ failure in sepsis. Nat Rev Nephrol. 14:417–427. 2018.PubMed/NCBI View Article : Google Scholar
7	Vincent JL, Ince C and Pickkers P: Endothelial dysfunction: A therapeutic target in bacterial sepsis? Expert Opin Ther Targets. 25:733–748. 2021.PubMed/NCBI View Article : Google Scholar
8	Gu H and Neel BG: The ‘Gab’ in signal transduction. Trends Cell Biol. 13:122–130. 2003.PubMed/NCBI View Article : Google Scholar
9	Sun L, Zhu H and Zhang K: GAB1 alleviates septic lung injury by inhibiting the TLR4/NF-κB pathway. Clin Exp Pharmacol Physiol. 49:94–103. 2022.PubMed/NCBI View Article : Google Scholar
10	Qiu N, Xu X and He Y: LncRNA TUG1 alleviates sepsis-induced acute lung injury by targeting miR-34b-5p/GAB1. BMC Pulm Med. 20(49)2020.PubMed/NCBI View Article : Google Scholar
11	Xiong Y, Wang Y, Tian H, Li Y, Xu Q and He Z: Circ-PRKCI alleviates lipopolysaccharide-induced human kidney 2 cell injury by regulating miR-106b-5p/GAB1 axis. J Cardiovasc Pharmacol. 78:523–533. 2021.PubMed/NCBI View Article : Google Scholar
12	Higuchi K, Nakaoka Y, Shioyama W, Arita Y, Hashimoto T, Yasui T, Ikeoka K, Kuroda T, Minami T, Nishida K, et al: Endothelial Gab1 deletion accelerates angiotensin II-dependent vascular inflammation and atherosclerosis in apolipoprotein E knockout mice. Circ J. 76:2031–2040. 2012.PubMed/NCBI View Article : Google Scholar
13	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 402-408:2001.PubMed/NCBI View Article : Google Scholar
14	Kolluru GK, Siamwala JH and Chatterjee S: eNOS phosphorylation in health and disease. Biochimie. 92:1186–1198. 2010.PubMed/NCBI View Article : Google Scholar
15	Aird WC: The role of the endothelium in severe sepsis and multiple organ dysfunction syndrome. Blood. 101:3765–3777. 2003.PubMed/NCBI View Article : Google Scholar
16	Page AV and Liles WC: Biomarkers of endothelial activation/dysfunction in infectious diseases. Virulence. 4:507–516. 2013.PubMed/NCBI View Article : Google Scholar
17	Joffre J, Hellman J, Ince C and Ait-Oufella H: Endothelial responses in sepsis. Am J Respir Crit Care Med. 202:361–370. 2020.PubMed/NCBI View Article : Google Scholar
18	Li Z, Yin M, Zhang H, Ni W, Pierce RW, Zhou HJ and Min W: BMX represses thrombin-PAR1-mediated endothelial permeability and vascular leakage during early sepsis. Circ Res. 126:471–485. 2020.PubMed/NCBI View Article : Google Scholar
19	Huang L, Li Y, Cheng Z, Lv Z, Luo S and Xia Y: PCSK9 promotes endothelial dysfunction during sepsis via the TLR4/MyD88/NF-κB and NLRP3 pathways. Inflammation. 46:115–128. 2023.PubMed/NCBI View Article : Google Scholar
20	Zhao L, Hu J, Zheng P, Mi B, Chen Z, Zhao X, Wu J and Wang Y: PAR1 regulates sepsis-induced vascular endothelial barrier dysfunction by mediating ERM phosphorylation via the RhoA/ROCK signaling pathway. Int Immunopharmacol. 124(110992)2023.PubMed/NCBI View Article : Google Scholar
21	Janaszak-Jasiecka A, Siekierzycka A, Płoska A, Dobrucki IT and Kalinowski L: Endothelial dysfunction driven by hypoxia-the influence of oxygen deficiency on no bioavailability. Biomolecules. 11(982)2021.PubMed/NCBI View Article : Google Scholar
22	Carow B and Rottenberg ME: SOCS3, a major regulator of infection and inflammation. Front Immunol. 5(58)2014.PubMed/NCBI View Article : Google Scholar
23	Jin D, Liu Y, Sun F, Wang X, Liu X and He Z: Restoration of skilled locomotion by sprouting corticospinal axons induced by co-deletion of PTEN and SOCS3. Nat Commun. 6(8074)2015.PubMed/NCBI View Article : Google Scholar
24	Martino N, Ramos RB, Lu S, Leyden K, Tomaszek L, Sadhu S, Fredman G, Jaitovich A, Vincent PA and Adam AP: Endothelial SOCS3 maintains homeostasis and promotes survival in endotoxemic mice. JCI Insight. 6(e147280)2021.PubMed/NCBI View Article : Google Scholar
25	Martino N, Bossardi Ramos R, Chuy D, Tomaszek L and Adam AP: SOCS3 limits TNF and endotoxin-induced endothelial dysfunction by blocking a required autocrine interleukin-6 signal in human endothelial cells. Am J Physiol Cell Physiol. 323:C556–C569. 2022.PubMed/NCBI View Article : Google Scholar
26	Jaśkiewicz A, Domoradzki T and Pająk B: Targeting the JAK2/STAT3 pathway-can we compare it to the two faces of the God Janus? Int J Mol Sci. 21(8261)2020.PubMed/NCBI View Article : Google Scholar
27	Yu Q, Wang H, Li X and Leng B: Effects of JAK2/STAT3 signaling pathway activation on sepsis-induced kidney injury. Minerva Med. 113:350–352. 2022.PubMed/NCBI View Article : Google Scholar
28	Zhen G, Liang W, Jia H and Zheng X: Melatonin relieves sepsis-induced myocardial injury via regulating JAK2/STAT3 signaling pathway. Minerva Med. 113:983–989. 2022.PubMed/NCBI View Article : Google Scholar
29	Lu Y, Li D, Huang Y, Sun Y, Zhou H, Ye F, Yang H, Xu T, Quan S and Pan J: Pretreatment with eupatilin attenuates inflammation and coagulation in sepsis by suppressing JAK2/STAT3 signaling pathway. J Inflamm Res. 16:1027–1042. 2023.PubMed/NCBI View Article : Google Scholar
30	Durham GA, Williams JJL, Nasim MT and Palmer TM: Targeting SOCS proteins to control JAK-STAT signalling in disease. Trends Pharmacol Sci. 40:298–308. 2019.PubMed/NCBI View Article : Google Scholar
31	Gao Y, Zhao H, Wang P, Wang J and Zou L: The roles of SOCS3 and STAT3 in bacterial infection and inflammatory diseases. Scand J Immunol. 88(e12727)2018.PubMed/NCBI View Article : Google Scholar